Tandem Diabetes Care, Inc. (TNDM) News

Tandem Diabetes Care, Inc. (TNDM): $30.15

2.28 (+8.18%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Filter TNDM News Items

TNDM News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TNDM News Highlights

  • For TNDM, its 30 day story count is now at 6.
  • Over the past 13 days, the trend for TNDM's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about TNDM are DXCM and HCP.

Latest TNDM News From Around the Web

Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump

Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.

Yahoo | December 19, 2023

Here's Why You Should Retain Tandem Diabetes (TNDM) Now

Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.

Yahoo | December 19, 2023

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.

Yahoo | December 14, 2023

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

SAN DIEGO, December 12, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now availabl

Yahoo | December 12, 2023

Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2

Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.

Yahoo | December 7, 2023

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

SAN DIEGO, December 06, 2023--Tandem Diabetes Care today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 CGM integration in the United States.

Yahoo | December 6, 2023

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?

Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ), might not be a large cap stock, but it received a lot of attention from a...

Yahoo | December 4, 2023

Why Is Tandem Diabetes Care, Inc. (TNDM) Up 33.2% Since Last Earnings Report?

Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023

Unomedical recall of infusion sets tagged as Class I by FDA

The company notified Tandem Diabetes Care, its sole consignee, in October of the risk for infusion sets to detach from insulin pumps, disrupting insulin delivery.

Yahoo | November 28, 2023

12 Best Diabetes Stocks To Buy Now

In this article, we shall discuss the 12 best diabetes stocks to buy now. To skip our detailed analysis of the global diabetes drugs industry in 2023, go directly and see 5 Best Diabetes Stocks to Buy Now. Diabetes is a chronic metabolic disease which is normally characterized by high blood glucose levels, which tend […]

Yahoo | November 26, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!